About 50% of people with diabetes may have a condition called gastroparesis. This happens when food stays in the stomach too long. It can make life hard, causing symptoms like nausea, vomiting, feeling full too soon, and bloating.
A new treatment might help. It’s called gastric pacemaker therapy, or gastric electrical stimulation (GES). This method uses a device to send electrical signals to the stomach. It aims to make the stomach work better and ease symptoms of gastroparesis.
For those with gastroparesis who don’t get better with other treatments, gastric pacemaker therapy could be a solution. It involves putting a device under the skin that sends gentle electrical signals to the stomach. This can help make the stomach move food along better. It could make living with gastroparesis easier.
Key Takeaways
- Gastroparesis is a chronic digestive disorder characterized by delayed gastric emptying and impaired stomach motility.
- Gastric electrical stimulation (GES) using implanted pacemakers is a promising treatment option for patients with drug-refractory gastroparesis.
- GES can help regulate the stomach’s neuromuscular function and improve symptoms such as nausea, vomiting, early satiety, and bloating.
- Gastric pacemaker therapy is considered medically necessary for the treatment of chronic, intractable gastroparesis of diabetic or idiopathic origin.
- Proper patient selection and management are crucial for the successful implementation of gastric pacemaker therapy.
Understanding Gastroparesis: A Chronic Digestive Disorder
Gastroparesis is a condition where the stomach moves food too slowly. This leads to delayed stomach emptying. People with this chronic digestive issue often feel nausea, vomiting, and other symptoms.
Symptoms and Causes of Delayed Gastric Emptying
Common symptoms of gastroparesis include:
- Nausea
- Vomiting
- Abdominal pain and bloating
- Feeling full too soon during meals
- Unintentional weight loss
There are many reasons why someone might get gastroparesis. The most common reasons are idiopathic (no known cause) and diabetic. Other causes include problems after surgery, nerve disorders, autoimmune diseases, and some medicines.
Gastroparesis Prevalence and Incidence
In the U.S., more people are being hospitalized for gastroparesis since 1995, especially after 2000. Studies show that more women than men get idiopathic gastroparesis. Also, people with type 1 diabetes often experience more symptoms and slow stomach emptying than those with type 2 over 10 years.
“Approximately 1 in 10 patients with gastroparesis are disabled by the condition.”
Pathophysiology of Gastroparesis: Unraveling the Mechanisms
The causes of gastroparesis are complex and involve many factors. These include issues with gastric motility, autonomic dysfunction, visceral hypersensitivity, and changes in enteric nerves and interstitial cells of Cajal. These factors lead to slow stomach emptying and symptoms in people with gastroparesis.
About 9.3% of people with diabetes might get gastroparesis. The condition is more common in some parts of the world, like Asia, Europe, South America, and Australia. In one study, more women than men got gastroparesis. The risk goes up with age, especially in those with diabetes for a long time.
The way the stomach moves food involves the nervous system and hormones like gastrin and CCK. Interstitial cells of Cajal help control this process. Diabetes can affect these cells and slow down stomach movement.
Vagal dysfunction is a big part of diabetic gastroparesis. It affects stomach contractions and how the body handles food. Treating the area around the stomach can help improve symptoms.
Studies have found that interstitial cells of Cajal are often damaged in gastroparesis. These cells are key to stomach movement. Looking closely at these cells can help understand and treat the condition better.
Treatment Strategies for Gastroparesis
Gastroparesis is a chronic digestive disorder that causes food to stay in the stomach too long. It’s tough to treat, but diet and medicine are key parts of treatment. A new therapy, gastric electrical stimulation (GES), is showing promise for those who don’t get better with usual treatments.
Dietary and Medical Management
First, doctors suggest changing your diet and using prokinetic medicines. These medicines, like Erythromycin and Metoclopramide, help move food through your stomach. Metoclopramide is the only FDA-approved drug for gastroparesis in the U.S. Sometimes, doctors also give anti-nausea medicines to help with vomiting.
But, some people with gastroparesis don’t get better with these treatments. This leads doctors to look for other ways to help.
Gastric Electrical Stimulation: A Promising Therapy
Gastric electrical stimulation (GES), or gastric pacing, is a new way to help people with gastroparesis who don’t respond to usual treatments. It uses electrodes on the stomach to help the muscles work better. This might make nausea and vomiting less severe. But, it’s still being studied to see how well it works.
Some doctors are also trying Botulinum toxin injections into the stomach muscles as a treatment. Results are not the same for everyone. Researchers are always looking for new ways to help people with gastroparesis.
“The introduction of cutting-edge advancements in medical implant technology has significantly improved treatment efficacy, reduced side effects, and provided targeted interventions for various medical conditions.”
Gastroparesis, gastric pacemakers: A Closer Look at GES
Gastric electrical stimulation, or gastric pacemaker therapy, is a new way to help people with gastroparesis. It’s for those who still have symptoms after trying other treatments. This method tries to fix the ongoing issues that don’t go away with usual treatments.
Mechanisms and Benefits of Gastric Electrical Stimulation
GES works by making the stomach’s natural electrical activity work better together. It helps the stomach muscles contract in a coordinated way. This can make the symptoms of gastroparesis, like nausea and vomiting, better.
GES also affects the autonomic nervous system and hormones in the body. These changes help improve how the stomach works and can make symptoms less severe.
- Synchronization of intrinsic gastric electrical activity
- Evoking propagating contractions to improve gastric motility
- Alleviation of gastroparesis symptoms, including nausea and vomiting
- Alteration of autonomic nervous system and hormonal activity
- Enhancement of gastric neuromodulation and overall gastric function
“Gastric electrical stimulation offers a promising therapeutic approach for individuals struggling with the debilitating symptoms of gastroparesis, providing a potential avenue for improved quality of life.”
Clinical Outcomes and Efficacy of Gastric Pacemakers
Gastric electrical stimulation (GES) has shown promising results for gastroparesis symptoms. This condition is marked by slow stomach emptying. Studies have looked at how gastric pacemakers affect symptoms like nausea, vomiting, and weight loss.
Impact on Nausea, Vomiting, and Weight Loss
Most studies found that GES therapy greatly reduced nausea and vomiting in patients with gastroparesis. Patients also saw their weight increase by up to 15 pounds in the first year after getting a GES implant.
Open-label studies showed better quality of life and improved GCSI scores. But, some randomized trials and meta-analyses didn’t see the same symptom relief. Still, other factors like inflammatory markers, insulin levels (especially in diabetics), and the number of, got better with gastric pacemakers.
“Approximately 50% of patients referred to the Center for Gastrointestinal Nerve and Motor Function receive gastric electrical stimulator (GES) implantation for gastroparesis management.”
Most patients (over 87%) like GES therapy and would choose it again. But, results can differ. One-third of patients with certain types of gastroparesis didn’t see much improvement. This is because they lacked interstitial cells of Cajal, important for stomach movement.
Overall, gastric pacemakers are a helpful tool for managing gastroparesis symptoms. They lead to better quality of life and less healthcare use for many patients.
Patient Selection and Contraindications for GES
Choosing the right patients is key for gastric pacemaker therapy to work well. Those with gastroparesis that doesn’t respond to diet and medicine might be good candidates. But, there are some things to think about first.
It’s important to look at why the patient has gastroparesis, their overall health, and the risks of the surgery. People allergic to food or diabetics with high blood sugar shouldn’t get a gastric pacemaker.
Getting ready for a gastric emptying scintigraphy exam is crucial. Patients should not eat for at least 4 hours before. Also, stop any medicines that slow down stomach emptying.
The Enterra™ Therapy System is the only FDA-approved gastric pacemaker for chronic nausea and vomiting from gastroparesis. It’s for people 18 to 70 years old. It’s not tested on pregnant women, kids under 18, or people over 70.
There are risks with GES therapy, like infections, pain, and stomach problems. Patients should avoid activities that could harm the device.
Choosing the right patients and knowing the risks is key for gastric pacemaker success. By understanding each patient’s situation, doctors can make the best treatment plan for those with hard-to-treat gastroparesis.
Future Directions and Research Needs
Gastric pacemaker therapy is showing promise in treating gastroparesis. Yet, more research is needed. Studies aim to understand the neural circuits involved and find the best patients for this therapy.
Improving gastric pacemaker technology is key to better managing this condition. Researchers are looking into new ways to make gastric electrical stimulation (GES) more effective for treating gastroparesis.
- Future research in gastroparesis focuses on understanding the condition better.
- Advances in gastric pacemaker technology aim to improve GES for patients.
- New treatment options for gastroparesis, like new stimulation methods or combining GES with other therapies, are being tested.
Addressing these research areas will help doctors tailor gastric pacemaker therapy for each patient. This could unlock the full potential of this promising treatment for gastroparesis.
“The future of gastroparesis treatment lies in the continued advancement of gastric pacemaker technology and the exploration of novel therapeutic approaches that can further improve patient outcomes.”
Improving Quality of Life with Gastric Pacemakers
Gastroparesis can really affect someone’s life, causing symptoms like nausea, vomiting, feeling full too soon, and stomach pain. But, gastric pacemakers offer hope for relief from this chronic issue.
These devices aim to make life better for those with gastroparesis by easing symptoms. A small device is implanted to send electrical signals to the stomach nerves. This helps control stomach contractions and speeds up digestion.
People using gastric pacemakers have seen big improvements, like less vomiting and better control over their symptoms. These changes happen in just a few weeks after the treatment.
“The gastric pacemaker has given me my life back. I no longer have to worry about constantly feeling nauseous or being sick. It’s been a game-changer for my quality of life.”
As research grows, gastric pacemakers show great promise for managing gastroparesis symptoms and improving life quality. With new tech and better patient selection, this treatment could change lives for the better.
Conclusion
Gastroparesis is a tough condition that can really affect someone’s life. Even with diet and medicine, many people don’t get better. But, gastric pacemaker therapy, or gastric electrical stimulation, is showing promise as a new way to help.
Studies show that gastric pacemaker therapy can help with symptoms like nausea, vomiting, and weight loss. It can also make life better overall. But, gastroparesis is complex, involving issues like slow stomach movement, nerve problems, and changes in the stomach’s nervous system. So, we need more research to make this therapy better and find new ways to treat it.
We’re looking forward to more progress in gastric pacemaker therapy and new treatments for gastroparesis. By learning more and improving treatments, doctors can help people with gastroparesis live better lives.
FAQ
What is gastroparesis?
What are the underlying causes of gastroparesis?
What are the current treatment options for gastroparesis?
How does gastric electrical stimulation (GES) work for gastroparesis?
What are the potential benefits of gastric pacemaker therapy for gastroparesis?
Who are the ideal candidates for gastric pacemaker therapy?
What are the future directions and research needs in gastroparesis management?
Source Links
- https://www.keystonefirstpa.com/pdf/provider/resources/clinical/policies-20200423/ccp1195-gastric-electrical-stimulation.pdf
- https://academic.oup.com/edrv/article/40/5/1318/5487986
- https://medschool.ucla.edu/news-article/gastroparesis-symptoms-treatment-and-causes
- https://rarediseases.org/rare-diseases/gastroparesis/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035159/
- https://www.mdpi.com/2624-5647/6/1/16
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429650/
- https://www.hopkinsmedicine.org/health/conditions-and-diseases/gastroparesis/gastroparesis-treatment
- https://www.mcw.edu/departments/surgery/divisions/minimally-invasive-and-gastrointestinal-surgery/patient-care/gerd-and-gastrointestinal-surgery-program/gastroparesis
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049171/
- https://www.southcarolinablues.com/web/public/brands/medicalpolicy/external-policies/gastric-electrical-stimulation/
- https://www.enterramedical.com/newsroom/enterra-ii-system-an-advanced-treatment-for-gastroparesis-receives-fda-approval-for-mr-conditional-use/
- https://www.medscape.com/viewarticle/460632_4
- https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.645472/full
- https://www.ncbi.nlm.nih.gov/books/NBK531503/
- https://www.medtronic.com/uk-en/patients/treatments-therapies/neurostimulator-gastroparesis/important-safety-information.html
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100207/
- https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2022.1035723/pdf
- https://www.stephenhancocks.com/download.php?op=view_article&article_id=1804
- https://blog.ttuhsc.edu/spirit5/2018/november/diabeticpatients.aspx
- https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.909149/full
- https://doc.uhealthplan.utah.edu/medicalpolicy/mp-015.pdf